Table 2.

Pearson’s correlation analysis between cholesterol efflux capacity and NMR-determined total plasma apolipoprotein A-I-rich lipoprotein and HDL-related lipoproteins in the non-CAD (n = 61) group and the CAD (n = 36) group.

	Non-CAD		CAD
	r	p	r	p
Total plasma apoA-I	0.369	0.004	0.086	0.618
Total-HDL-triglycerides	0.014	0.918	− 0.190	0.267
Total-HDL-phospholipids	0.338	0.009	− 0.028	0.871
Total-HDL-free cholesterol	0.282	0.032	0.228	0.182
Total-HDL-apoA-I	0.400	0.002	0.070	0.687
Total-HDL-apoA-II	0.340	0.009	− 0.071	0.681
HDL1-cholesterol	0.285	0.030	− 0.159	0.354
HDL1-triglycerides	0.116	0.384	− 0.230	0.178
HDL1-phospholipids	0.231	0.081	− 0.194	0.256
HDL1-free cholesterol	0.246	0.063	0.089	0.604
HDL1-apoA-I	0.223	0.092	− 0.179	0.297
HDL1-apoA-II	0.165	0.217	− 0.258	0.128
HDL2-cholesterol	0.289	0.028	− 0.116	0.499
HDL2-triglycerides	0.035	0.795	− 0.220	0.197
HDL2-phospholipids	0.208	0.116	− 0.209	0.222
HDL2-free cholesterol	0.181	0.173	0.044	0.798
HDL2-apoA-I	0.221	0.096	− 0.198	0.247
HDL2-apoA-II	0.137	0.305	− 0.233	0.171
HDL3-cholesterol	0.319	0.015	0.015	0.933
HDL3-triglycerides	0.021	0.878	− 0.205	0.231
HDL3-phospholipids	0.236	0.074	− 0.091	0.600
HDL3-free cholesterol	0.210	0.113	0.112	0.516
HDL3-apoA-I	0.246	0.063	− 0.085	0.622
HDL3- apoA-II	0.155	0.246	− 0.182	0.287
HDL4-cholesterol	0.224	0.091	0.242	0.155
HDL4-triglycerides	0.077	0.566	0.008	0.961
HDL4-phospholipids	0.206	0.120	0.216	0.205
HDL4- free cholesterol	0.194	0.145	0.260	0.126
HDL4-apoA-I	0.238	0.072	0.250	0.141
HDL4-apoA-II	0.182	0.171	0.223	0.192

CEC, cholesterol efflux capacity; NMR, nuclear magnetic resonance; HDL, high-density lipoprotein; CAD, coronary artery disease; ApoA-I, apolipoprotein A-I; ApoA-II, apolipoprotein A-II. Boldface type emphasizes significant changes.